![Richard Bagley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard Bagley
President at Samus Therapeutics, Inc.
Richard Bagley active positions
Companies | Position | Start | End |
---|---|---|---|
Samus Therapeutics, Inc.
![]() Samus Therapeutics, Inc. BiotechnologyHealth Technology Samus Therapeutics, Inc. operates as an biopharmaceutical company. It develops novel therapeutics targeting the epichaperome to enhance degradation of aberrant proteins which drive the pathology of diseases such as neurodegenerative and cancer. The company is headquartered in Topsfield, MA. | President | 2016-10-31 | - |
Career history of Richard Bagley
Former positions of Richard Bagley
Companies | Position | Start | End |
---|---|---|---|
ALAUNOS THERAPEUTICS, INC. | Director/Board Member | 2011-06-22 | 2012-07-15 |
Chief Operating Officer | 2005-08-31 | 2012-07-15 | |
Director of Finance/CFO | 2005-08-31 | 2012-05-08 | |
President | 2005-08-31 | 2012-07-15 | |
Treasurer | 2005-08-31 | 2012-07-08 | |
ZIOPHARM, Inc. | Chief Operating Officer | 2004-06-30 | 2005-08-31 |
President | 2004-06-30 | 2005-08-31 | |
TWIN BUTTE ENERGY LTD. | President | 1997-12-31 | 2003-04-30 |
ProScript, Inc.
![]() ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | Chairman | 1993-12-31 | 1997-12-31 |
President | 1993-12-31 | 1997-12-31 | |
ImmuLogic Pharmaceutical Corp.
![]() ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | President | 1989-12-31 | 1993-12-31 |
E. R. Squibb & Sons LLC | President | 1987-12-31 | 1988-12-31 |
Smithkline & French Laboratories US, Inc. | Corporate Officer/Principal | 1967-12-31 | 1984-12-31 |
Training of Richard Bagley
Harvard Graduate School of Education | Graduate Degree |
Statistics
International
United States | 9 |
Canada | 2 |
Operational
President | 7 |
Chief Operating Officer | 2 |
Director/Board Member | 1 |
Sectoral
Health Technology | 6 |
Energy Minerals | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
ALAUNOS THERAPEUTICS, INC. | Health Technology |
TWIN BUTTE ENERGY LTD. | Energy Minerals |
Private companies | 6 |
---|---|
ImmuLogic Pharmaceutical Corp.
![]() ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | Health Technology |
ProScript, Inc.
![]() ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | Health Technology |
ZIOPHARM, Inc. | Health Technology |
Smithkline & French Laboratories US, Inc. | |
E. R. Squibb & Sons LLC | |
Samus Therapeutics, Inc.
![]() Samus Therapeutics, Inc. BiotechnologyHealth Technology Samus Therapeutics, Inc. operates as an biopharmaceutical company. It develops novel therapeutics targeting the epichaperome to enhance degradation of aberrant proteins which drive the pathology of diseases such as neurodegenerative and cancer. The company is headquartered in Topsfield, MA. | Health Technology |
- Stock Market
- Insiders
- Richard Bagley
- Experience